Digital Health Hub

Discover Cambridge, London and Oxford for life sciences

Join us to transform the future of healthcare.

Meet the digital health pioneers from the golden triangle of Cambridge, London and Oxford, that are making their mark in healthcare through a combination of technology and science. Learn more about their passion and inspiration for digital health and the role the golden triangle is playing in the future of healthcare.

"We are creating an ecosystem here with an incredible combination of talent from tech and from the life sciences. We are a global leader now and we will continue to be a global leader in the future."

Sarah Kerruish, Chief Strategy and Growth Officer, Antidote

Report: A Digital Health Hub

We spoke to experts from industry, academia and the UK National Health Service (NHS) about the thriving digital health ecosystem.

Read the report to learn about the opportunities for you in the golden triangle of Cambridge, London and Oxford.

Read the report

Stories

Digital Health Hub Oxford

Data-driven biomarkers in Oxford

Oxford based Isansys is creating a new class of data-driven biomarkers. Take the work they are doing with hepatologists at the Royal Free Hospital in London: the data from just one wireless wearable sensor patch taken over a 20-minute period is equivalent to the data and information content traditionally obtained from a blood test which takes hours of lab time and requires the patient to attend the hospital. This is a major shift towards data-driven methods - it is, quite possibly, the emergence of a new paradigm. They have received significant support from the Oxford Academic Health Science Network (AHSN). “The AHSN recognised the power of what we’re doing and how it runs across a range of clinical sectors,” says Keith Errey, CEO of Isansys Lifecare. "It was with their help and support that we received Phase 1 and Phase 2 funding from Innovate UK through the SBRI programme and were able to transform our system from being ‘something interesting’ into a complete scaled system; bringing benefits to patients and clinicians in the shortest possible timescale."

digital health hub london

Genomic analysis in London

London based Seven Bridges UK is a biomedical data analysis company focused on connecting the world’s biomedical data and make it useful. Seven Bridges provides a user-friendly platform for genomic analysis. As next-generation sequencing costs fall for human DNA, more and more data is being produced which needs to be analysed before it can be useful for clinical decision making. They opened their first overseas office in London two and a half years ago, responding to political and policy announcements in the UK.
The 100,000 Genome Project in particular has created a vibrant genomics environment in the UK. Last year they received a Small Business Research Initiative (SBRI) grant from the Department of Health and Genomics England to complete and launch an analysis tool for highly accurate variant calling using population genome graphs.

digital-health-hub-cambridge 2

Cambridge Cognition

Cambridge Cognition translates gold standard neuroscience research into tools that are usable and practical for doctors, researchers, and patients. These tools make the drug development process more efficient, through their development of software based on new insights into neuroscience that flow out of nearby Cambridge University. The company are interested in not only helping to develop new drugs but also in how mobile health can: help to make drugs more effective; or enable patients to better manage their health; or measure precisely how and when they use their drugs. This information then positions them to make a digital health case for the drug, beyond the simple assessment of its efficacy in a lab.

Digital Health in Cambridge UK

Cambridge Cognition - Collaboration

Cambridge Cognition translates gold standard neuroscience research into tools that are usable and practical for doctors, researchers, and patients. These tools make the drug development process more efficient, through their development of software based on new insights into neuroscience that flow out of nearby Cambridge University. The company are interested in not only helping to develop new drugs but also in how mobile health can: help to make drugs more effective; or enable patients to better manage their health; or measure precisely how and when they use their drugs. This information then positions them to make a digital health case for the drug, beyond the simple assessment of its efficacy in a lab.

Digital Health in London  - Isansys - UK

Isansys

Oxford based Isansys is creating a new class of data-driven biomarkers. Take the work they are doing with hepatologists at the Royal Free Hospital in London: the data from just one wireless wearable sensor patch taken over a 20-minute period is equivalent to the data and information content traditionally obtained from a blood test which takes hours of lab time and requires the patient to attend the hospital. This is a major shift towards data-driven methods - it is, quite possibly, the emergence of a new paradigm. They have received significant support from the Oxford Academic Health Science Network (AHSN). “The AHSN recognised the power of what we’re doing and how it runs across a range of clinical sectors,” says Keith Errey, CEO of Isansys Lifecare. "It was with their help and support that we received Phase 1 and Phase 2 funding from Innovate UK through the SBRI programme and were able to transform our system from being ‘something interesting’ into a complete scaled system; bringing benefits to patients and clinicians in the shortest possible timescale."

Join Us to Transform the Future of Healthcare

Contact us to find out how you can be a part of the world-leading life sciences hub of Cambridge, London and Oxford.

Based on your requirements, you may be contacted by the Department for International Trade, London & Partners, the Mayor of London's International Business Programme or MedCity.

Contact Us